Influence of metabolic profiles on the safety of drug therapy in routine care in Germany: protocol of the cohort study EMPAR

por Huebner, Tatjana, Steffens, Michael, Linder, Roland, Fracowiak, Jochen, Langner, Daria, Garling, Marco, Falkenberg, Felix, Roethlein, Christoph, Gomm, Willy, Haenisch, Britta, Stingl, Julia
Publicado 2020

Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study

por Just, Katja S., Dormann, Harald, Schurig, Marlen, Böhme, Miriam, Fracowiak, Jochen, Steffens, Michael, Scholl, Catharina, Seufferlein, Thomas, Gräff, Ingo, Schwab, Matthias, Stingl, Julia C.
Publicado 2020

Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes

por Fracowiak, Jochen, Huebner, Tatjana, Heß, Steffen, Roethlein, Christoph, Langner, Daria, Schneider, Udo, Falkenberg, Felix, Scholl, Catharina, Linder, Roland, Stingl, Julia, Haenisch, Britta, Steffens, Michael
Publicado 2022